Crohn's Disease and Colitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with Crohn's disease.
- You are between 19 and 79 years old.
- You are either not taking any medication, or you have been on a stable medication routine throughout the study — this includes mesalazine (at least 6 weeks), steroids (at least 2 weeks), immune-suppressing drugs (at least 12 weeks), biologic treatments (at least 12 weeks), or medical cannabis (at least 2 weeks).
- Your Crohn's disease symptoms are considered active, based on a symptom score above 4 on a standard Crohn's disease scoring tool, or a stool test showing raised inflammation levels (confirm with trial site).
Who may not be able to join:
- Your Body Mass Index (BMI) is over 30 (considered obese range).
- You currently have a confirmed infection, such as a gut bacterial infection, a positive stool culture, or a parasitic infection.
- You are unable to give consent or follow the study requirements.
- You are pregnant.
- You have another serious long-term condition such as cancer, have had an organ transplant, or have advanced kidney or liver disease, or another inflammatory condition unrelated to Crohn's disease.
- You have cysts or abscesses on your liver, kidneys, or pancreas.
- You have an abscess in your abdomen or an abnormal connection between parts of your intestines.
- You have had more than one Crohn's-related bowel surgery, or your small intestine is shorter than usual due to surgery (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nitsan Maharshak, Professor, Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
Phone: +972527360384
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Assess the safety of fIR therapy for CD patients.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.